Dupont Jakob - Insider Non-Derivative Transactions at Pyxis Oncology, Inc. (PYXS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 26, 2024, Dupont Jakob's relationship to Pyxis Oncology, Inc. (PYXS) is Director, and currently has 38,741 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PYXS insiders.
Data Source: SEC.
Dupont Jakob - Insider Non-Derivative Transactions at PYXS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 27, 2024 | Acquisition -- (Common Stock) | 38741 | 0 | 38741 |